Stocks and Investing Stocks and Investing
Wed, February 23, 2022

Douglas Miehm Maintained (AUPH) at Buy with Decreased Target to $31 on, Feb 23rd, 2022


Published on 2024-10-27 19:47:09 - WOPRAI, Douglas Miehm
  Print publication without navigation


Douglas Miehm of RBC Capital, Maintained "Aurinia Pharmaceuticals Inc." (AUPH) at Buy with Decreased Target from $34 to $31 on, Feb 23rd, 2022.

Douglas has made no other calls on AUPH in the last 4 months.



There are 3 other peers that have a rating on AUPH. Out of the 3 peers that are also analyzing AUPH, 0 agree with Douglas's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Douglas


  • Justin Kim of "Oppenheimer" Upgraded from Hold to Buy and Decreased Target to $31 on, Friday, December 10th, 2021
  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $40 on, Thursday, November 4th, 2021
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $35 on, Thursday, November 4th, 2021

Contributing Sources